Investors Research Corp’s Amgen AMGN Stock Holding History

Investors Research Corp’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-39	Closed	-$12.8K	–	849
2025 Q4	$12.8K	Hold	39	–	–	﹤0.01%	600
2025 Q3	$11K	Hold	39	–	–	﹤0.01%	632
2025 Q2	$10.9K	Hold	39	–	–	﹤0.01%	663
2025 Q1	$12.2K	Buy	+39	New	+$11.5K	﹤0.01%	654
2024 Q3	–	Sell	-53	Closed	-$16.6K	–	975
2024 Q2	$16.6K	Hold	53	–	–	﹤0.01%	650
2024 Q1	$15.1K	Hold	53	–	–	﹤0.01%	659
2023 Q4	$15.3K	Hold	53	–	–	﹤0.01%	679
2023 Q3	$14.2K	Hold	53	–	–	﹤0.01%	703
2023 Q2	$11.8K	Hold	53	–	–	﹤0.01%	730
2023 Q1	$12.8K	Hold	53	–	–	﹤0.01%	734
2022 Q4	$13.9K	Buy	53 +39	+279%	+$10.5K	﹤0.01%	719
2022 Q3	$3K	Buy	+14	New	+$3.39K	﹤0.01%	909
2021 Q1	–	Sell	-250	Closed	-$57K	–	973
2020 Q4	$57K	Hold	250	–	–	0.02%	514
2020 Q3	$64K	Hold	250	–	–	0.03%	459
2020 Q2	$59K	Hold	250	–	–	0.03%	451
2020 Q1	$51K	Hold	250	–	–	0.03%	443
2019 Q4	$60K	Hold	250	–	–	0.03%	490
2019 Q3	$48K	Hold	250	–	–	0.02%	516
2019 Q2	$46K	Hold	250	–	–	0.02%	512
2019 Q1	$47K	Buy	+250	New	+$47.7K	0.03%	516

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Investors Research Corp's AMGN Position: Q1 2026 in Review

Investors Research Corp sold out of Amgen (AMGN) in Q1 2026, closing a stake of 39 shares — an estimated $12.8K sold.

Investors Research Corp first reported a position in AMGN in Q1 2019 and held it in 20 quarters. The position peaked at $64K in Q3 2020. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Investors Research Corp reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Investors Research Corp sold 39 Amgen shares in Q1 2026, an estimated $12.8K.
Investors Research Corp first reported a position in Amgen in Q1 2019 and held it in 20 quarters.
Investors Research Corp's Amgen position peaked at $64K in Q3 2020.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Investors Research Corp's 13F filing for Q1 2026, filed 3 Apr 2026.